
Can Stem Cells Help With Alopecia Areata?
7 min readSmall human studies show real hair regrowth signals for stem cell approaches in alopecia areata, but no cell or exosome product is FDA-approved or placebo-tested.
An independent reference library on stem cell therapy and cancer immunotherapy research.
471 articles · 2 topics · 351 Stem Cell Research · 120 Cancer Immunotherapy
Step 1 — Topic
Step 2 — Category
All 471 articles

Small human studies show real hair regrowth signals for stem cell approaches in alopecia areata, but no cell or exosome product is FDA-approved or placebo-tested.

From heart attack to critical limb ischemia, cardiovascular stem cell evidence splits sharply by subtype — here's where research actually stands for each.

The Diabetes Prevention Program cut type 2 diabetes risk by 58% with modest lifestyle change. Review the evidence for weight, activity, whole grains, sleep and screening.

ALS explained: causes, symptoms, the three FDA-approved drugs, and where stem cell research like NurOwn and Neuronata-R actually stands.

The FDA approved Tecentriq plus chemotherapy for dMMR stage III colon cancer after the NCI-funded ATOMIC trial cut recurrence risk by roughly half. Here's what it means.

ASGCT’s 30th Annual Meeting is confirmed for May 3–7, 2027 in Philadelphia. What to watch in gene therapy, stem cell science and engineered immune cells.

How cells, scaffolds and signals combine to engineer tissue — from bladder and cornea grafts to the unresolved challenges of blood supply and manufacturing.

Why sincere patient stories cannot establish treatment efficacy, and how selection bias, placebo effects and natural symptom changes can mislead.

Cell-tracking studies show lung trapping and limited tissue homing after IV MSC delivery; paracrine signaling may explain much of the plausible benefit.

Intismeran plus Keytruda met the INTerpath-001 melanoma trial’s recurrence and distant-metastasis endpoints; full statistics and survival data remain pending.

Beta-thalassemia is one of the few conditions stem cells already cure: matched-sibling HSCT and the FDA-approved gene therapies Zynteglo and Casgevy, with real caveats.

Korea's regulator restricts human-derived exosomes in cosmetics and bans exosome ad claims. What's actually sold in Seoul, and what the safety literature shows.
Every feature article on regenmedreview carries a Sources block listing its references. Where the original source material included no external citations, that is stated explicitly rather than left blank.